Literature DB >> 23204787

Soft tissue sarcoma-review of experience at a tertiary care cancer centre.

N K Shukla1, S V S Deo.   

Abstract

This study is a retrospective analysis of prospective data base of soft tissue sarcoma (STS) maintained in the department of Surgical Oncology, Bhim Rao Ambedkar Institute Rotary Cancer Hospital (BRA-IRCH), All India Institute of Medical Sciences, which is a tertiary care cancer centre. A total of 300 patients of STS were treated between 1995 and 2006. The mean age at presentation was 40.6 years and males were more affected then females. Extremity sarcomas were more common than non extremity sarcoma and lower limb dominated upper limb. The median size of tumor was 8 cm (range 1-40 cm). MRI scan was the preferred imaging modality and tissue diagnosis was obtained by core biopsy. Synovial Sarcoma and Malignant Fibrous Histiocytoma were the common histology. Majority (75%) tumors were of high grade. Patients were staged according to MSKCC staging system. Limb Salvage Surgery was offered to all patients where ever feasible. Wide excision with a gross three dimensional tumor free margin of 2 cm was performed. Adjuvant external beam radiotherapy was offered to all high grades, large and recurrent tumors along with perioperative brachytherapy implant for tumor bed. High grade tumors were also offered adjuvant Adriamycin based Chemotherapy. Limb salvage rate was 68% in extremity sarcoma. During follow up 114 (38%) patients had relapse of disease mainly systemic, lungs being the commonest site.

Entities:  

Keywords:  Adjuvant therapy; Maginant mesenchymal tumors; Perioperative brachytherapy; Soft tissue sarcoma; Surical resection

Year:  2012        PMID: 23204787      PMCID: PMC3338139          DOI: 10.1007/s13193-011-0119-x

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  12 in total

Review 1.  Soft-tissue sarcomas in adults.

Authors:  Matthew A Clark; Cyril Fisher; Ian Judson; J Meirion Thomas
Journal:  N Engl J Med       Date:  2005-08-18       Impact factor: 91.245

2.  Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.

Authors: 
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

Review 3.  Reconstructive approaches in soft tissue sarcoma.

Authors:  H N Langstein; G L Robb
Journal:  Semin Surg Oncol       Date:  1999 Jul-Aug

Review 4.  Randomized clinical trials in soft tissue sarcoma.

Authors:  Martin D Mccarter; David P Jaques; Murray F Brennan
Journal:  Surg Oncol Clin N Am       Date:  2002-01       Impact factor: 3.495

5.  Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.

Authors:  L Guillou; J M Coindre; F Bonichon; B B Nguyen; P Terrier; F Collin; M O Vilain; A M Mandard; V Le Doussal; A Leroux; J Jacquemier; H Duplay; X Sastre-Garau; J Costa
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

6.  Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.

Authors:  Jürgen Weitz; Christina R Antonescu; Murray F Brennan
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

Review 7.  Amputation for soft-tissue sarcoma.

Authors:  Matthew A Clark; J Meirion Thomas
Journal:  Lancet Oncol       Date:  2003-06       Impact factor: 41.316

Review 8.  The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.

Authors:  E Bastiaannet; H Groen; P L Jager; D C P Cobben; W T A van der Graaf; W Vaalburg; H J Hoekstra
Journal:  Cancer Treat Rev       Date:  2004-02       Impact factor: 12.111

9.  Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease.

Authors:  B E Demas; R T Heelan; J Lane; R Marcove; S Hajdu; M F Brennan
Journal:  AJR Am J Roentgenol       Date:  1988-03       Impact factor: 3.959

10.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

View more
  2 in total

1.  Prognostic Factors in Indian Patients Operated for Soft Tissue Sarcomas-a Retrospective Cross-sectional Analysis.

Authors:  Akshay Tiwari; Swati Shah; Ashwani Kumar Sharma; Sandeep Mehta; Ullas Batra; S K Sharma; A K Dewan
Journal:  Indian J Surg Oncol       Date:  2016-11-02

2.  Outcomes of Wide Resection of Soft-Tissue Sarcoma of the Extremity: A Retrospective Analysis.

Authors:  Ajay Sheoran; Abhishek Garg; Umesh Yadav; Zile Singh Kundu; Ravi Sherawat; Mohit Singla; Mudit Nemani; Deepender Wason; Harshdeep Singh Kulaar; Sabuj Baran Singha
Journal:  Cureus       Date:  2022-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.